Ren-ai Xu

1.2k total citations
93 papers, 878 citations indexed

About

Ren-ai Xu is a scholar working on Pharmacology, Molecular Biology and Pharmacology. According to data from OpenAlex, Ren-ai Xu has authored 93 papers receiving a total of 878 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Pharmacology, 26 papers in Molecular Biology and 19 papers in Pharmacology. Recurrent topics in Ren-ai Xu's work include Pharmacogenetics and Drug Metabolism (25 papers), Chronic Myeloid Leukemia Treatments (13 papers) and Analytical Methods in Pharmaceuticals (12 papers). Ren-ai Xu is often cited by papers focused on Pharmacogenetics and Drug Metabolism (25 papers), Chronic Myeloid Leukemia Treatments (13 papers) and Analytical Methods in Pharmaceuticals (12 papers). Ren-ai Xu collaborates with scholars based in China, Italy and United Kingdom. Ren-ai Xu's co-authors include Guoxin Hu, Xiangjun Qiu, Guanyang Lin, Ren‐Shan Ge, Jianping Cai, Jingjing Chen, Yuanyuan Shao, Yanan Liu, Jinyu Hu and Jianchang Qian and has published in prestigious journals such as SHILAP Revista de lepidopterología, Analytical Biochemistry and Journal of Ethnopharmacology.

In The Last Decade

Ren-ai Xu

86 papers receiving 867 citations

Peers

Ren-ai Xu
Guorong Fan China
Oliver Hatley United Kingdom
Xinan Wu China
Hongwei Fan China
Utpal Nandi India
Yunfang Zhou China
Pradeep Sharma United Kingdom
Harri G. Ramjit United States
Feifei Du China
Guorong Fan China
Ren-ai Xu
Citations per year, relative to Ren-ai Xu Ren-ai Xu (= 1×) peers Guorong Fan

Countries citing papers authored by Ren-ai Xu

Since Specialization
Citations

This map shows the geographic impact of Ren-ai Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ren-ai Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ren-ai Xu more than expected).

Fields of papers citing papers by Ren-ai Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ren-ai Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ren-ai Xu. The network helps show where Ren-ai Xu may publish in the future.

Co-authorship network of co-authors of Ren-ai Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Ren-ai Xu. A scholar is included among the top collaborators of Ren-ai Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ren-ai Xu. Ren-ai Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Song, Jin Woo, et al.. (2025). Prevalence of on time administration of carbapenem and its impact on PK/PD target attainment in hospitalized patients: a multicenter retrospective study. Frontiers in Cellular and Infection Microbiology. 15. 1690269–1690269.
2.
Wang, Jing, Yingying Hu, Qingqing Li, et al.. (2024). Effects of myricetin and quercetin on ticagrelor metabolism and the underlying mechanism. Chemico-Biological Interactions. 392. 110924–110924. 5 indexed citations
3.
Xia, Hailun, et al.. (2024). Effect of isavuconazole on the pharmacokinetics of sunitinib and its mechanism. BMC Cancer. 24(1). 1 indexed citations
4.
Shi, Lu, et al.. (2024). Simultaneous determination of iguratimod and its metabolite in rat plasma using a UPLC-MS/MS method: Application for drug-drug interaction. Journal of Pharmaceutical and Biomedical Analysis. 243. 116079–116079.
5.
Zhang, Li‐Qun, Xinyue Li, Lianguo Chen, et al.. (2024). Genetic variants, haplotype determination, and function of novel alleles of CYP2B6 in a Han Chinese population. Heliyon. 10(7). e28952–e28952. 1 indexed citations
6.
Xia, Hailun, et al.. (2024). Development of UPLC–MS/MS method for studying the pharmacokinetic interactions of fuzuloparib with curcumin in rats. Journal of Pharmaceutical and Biomedical Analysis. 249. 116383–116383. 1 indexed citations
7.
Xia, Mengming, et al.. (2024). The Pharmacokinetic Interaction of Tirabrutinib with Voriconazole,Itraconazole, and Fluconazole in SD Rats by UPLC-MS/MS. Current Medicinal Chemistry. 31(34). 5612–5619.
8.
Xu, Ren-ai, et al.. (2024). Preparation and evaluation of transdermal permeation of Huperzine A ethosomes gel in vitro. BMC Pharmacology and Toxicology. 25(1). 21–21. 6 indexed citations
9.
Li, Qingqing, Jing Wang, Yuxin Shen, et al.. (2023). The impacts of CYP3A4 genetic polymorphism and drug interactions on the metabolism of lurasidone. Biomedicine & Pharmacotherapy. 168. 115833–115833. 5 indexed citations
10.
Gao, Yijun, et al.. (2023). Combination therapy using multifunctional dissolvable hyaluronic acid microneedles for oral ulcers. International Journal of Biological Macromolecules. 251. 126333–126333. 23 indexed citations
11.
12.
Xu, Xinhao, Jinyu Hu, Yingying Hu, et al.. (2023). Applications of human and bovine serum albumins in biomedical engineering: A review. International Journal of Biological Macromolecules. 253(Pt 3). 126914–126914. 70 indexed citations
13.
Li, Qingqing, et al.. (2023). Effects of CYP2C19 inhibitors on mavacamten pharmacokinetics in rats based on UPLC-MS/MS. Chemico-Biological Interactions. 380. 110531–110531. 3 indexed citations
14.
Liu, Yanan, Jie Chen, Jing Wang, et al.. (2023). Effects of drug-drug interactions and CYP3A4 variants on alectinib metabolism. Archives of Toxicology. 97(8). 2133–2142. 5 indexed citations
15.
He, Jiayang, et al.. (2018). Inhibitory effect of celecoxib on agomelatine metabolism in vitro and in vivo. Drug Design Development and Therapy. Volume 12. 513–519. 13 indexed citations
16.
17.
Hu, Lufeng, Ren-ai Xu, Zhe Wang, et al.. (2012). Simultaneous determination of four cytochrome p450 probe drugs in rat plasma by a simple liquid chromatography–mass spectrometry method. Latin American Journal of Pharmacy. 3 indexed citations
18.
Huang, Zhenzhen, et al.. (2012). Simultaneous Determination of Three Bioactive Compounds in Traditional Chinese Medicine Patent Prescription Zuojin Pill by HPLC. Latin American Journal of Pharmacy. 1 indexed citations
19.
Lin, Guanyang, Haiyang Zhang, Feng Xue, et al.. (2011). Determination of meropenem in rabbit plasma by LC-MS/MS. Latin American Journal of Pharmacy. 2 indexed citations
20.
Wang, Xianqin, Jiayin Zhu, Ren-ai Xu, et al.. (2010). Determination of piracetam in rat plasma by LC–MS/MS and its application to pharmacokinetics. Biomedical Chromatography. 24(10). 1108–1112. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Guorong Fan Breakdown of academic impact, for papers by Oliver Hatley Breakdown of academic impact, for papers by Xinan Wu Breakdown of academic impact, for papers by Hongwei Fan Breakdown of academic impact, for papers by Utpal Nandi Breakdown of academic impact, for papers by Yunfang Zhou Breakdown of academic impact, for papers by Pradeep Sharma Breakdown of academic impact, for papers by Harri G. Ramjit Breakdown of academic impact, for papers by Feifei Du
Rankless by CCL
2026